Gisslén M - Search Results

1

Changes in cerebrospinal fluid proteins across the spectrum of untreated and treated chronic HIV-1 infection.

Hu Z, Cinque P, Dravid A, Hagberg L, Yilmaz A, Zetterberg H, Fuchs D, Gostner J, Blennow K, Spudich SS, Kincer L, Zhou S, Joseph SB, Swanstrom R, Price RW, Gisslén M. Hu Z, et al. Among authors: gisslen m. PLoS Pathog. 2024 Sep 24;20(9):e1012470. doi: 10.1371/journal.ppat.1012470. eCollection 2024 Sep. PLoS Pathog. 2024. PMID: 39316609 Free PMC article.

2

Tryptophan concentrations increase in cerebrospinal fluid and blood after zidovudine treatment in patients with HIV type 1 infection.

Gisslén M, Larsson M, Norkrans G, Fuchs D, Wachter H, Hagberg L. Gisslén M, et al. AIDS Res Hum Retroviruses. 1994 Aug;10(8):947-51. doi: 10.1089/aid.1994.10.947. AIDS Res Hum Retroviruses. 1994. PMID: 7529033

3

Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study.

Gisslén M, Chiodi F, Fuchs D, Norkrans G, Svennerholm B, Wachter H, Hagberg L. Gisslén M, et al. Scand J Infect Dis. 1994;26(5):523-33. doi: 10.3109/00365549409011810. Scand J Infect Dis. 1994. PMID: 7855550

4

Elevated cerebrospinal fluid sulfatide concentrations as a sign of increased metabolic turnover of myelin in HIV type I infection.

Gisslén M, Fredman P, Norkrans G, Hagberg L. Gisslén M, et al. AIDS Res Hum Retroviruses. 1996 Jan 20;12(2):149-55. doi: 10.1089/aid.1996.12.149. AIDS Res Hum Retroviruses. 1996. PMID: 8834465

5

Intrathecal immunoactivation in patients with HIV-1 infection is reduced by zidovudine but not by didanosine.

Hagberg L, Norkrans G, Gisslen M, Wachter H, Fuchs D, Svennerholm B. Hagberg L, et al. Among authors: gisslen m. Scand J Infect Dis. 1996;28(4):329-33. doi: 10.3109/00365549609037914. Scand J Infect Dis. 1996. PMID: 8893393 Clinical Trial.

6

Increase of tryptophan in serum and in cerebrospinal fluid of patients with HIV infection during zidovudine therapy.

Fuchs D, Gisslén M, Larsson M, Norkrans G, Hagberg L, Wachter H. Fuchs D, et al. Among authors: gisslen m. Adv Exp Med Biol. 1996;398:131-4. doi: 10.1007/978-1-4613-0381-7_21. Adv Exp Med Biol. 1996. PMID: 8906255

7

Increased cerebrospinal fluid ganglioside GM1 concentrations indicating neuronal involvement in all stages of HIV-1 infection.

Gisslén M, Hagberg L, Norkrans G, Lekman A, Fredman P. Gisslén M, et al. J Neurovirol. 1997 Apr;3(2):148-52. doi: 10.3109/13550289709015804. J Neurovirol. 1997. PMID: 9111177

8

The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine.

Gisslén M, Norkrans G, Svennerholm B, Hagberg L. Gisslén M, et al. J Infect Dis. 1997 Feb;175(2):434-7. doi: 10.1093/infdis/175.2.434. J Infect Dis. 1997. PMID: 9203666

9

HIV-1 RNA is not detectable in the cerebrospinal fluid during antiretroviral combination therapy.

Gisslén M, Hagberg L, Svennerholm B, Norkrans G. Gisslén M, et al. AIDS. 1997 Jul 15;11(9):1194. doi: 10.1097/00002030-199709000-00022. AIDS. 1997. PMID: 9233474 No abstract available.

10

Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment: a longitudinal study.

Gisslén M, Hagberg L, Fuchs D, Norkrans G, Svennerholm B. Gisslén M, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):291-5. doi: 10.1097/00042560-199804010-00001. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9525428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters